A study by the University of Pennsylvania shows that health insurance plans with limited networks do not include places that belong to the National Comprehensive Cancer Network and other cancer centers that are among the best in the country.
In a recent opinion column in Forbes, Grace-Marie Turner, founder and president of the Galen Institute, a nonprofit public policy research organization, said biosimilar prescription pharmaceuticals can provide an avenue to keeping drug prices low.
The ALS Association has joined the Muscular Dystrophy Association and the Les Turner ALS Foundation in opposing a plan that would eliminate federal funding for the Centers for Disease Control and Prevention's National ALS Registry.
A drug formerly meant for cancer treatment may be better used to treat muscular dystrophy, according to researchers from the National Institutes of Health (NIH) and the University of Nevada, Reno School of Medicine.
Jeremy Wynes, a Republican candidate U.S. representative in Illinois' 10th Congressional District, took to social media after the New York Times (NYT) estimated that 45 counties and up to 35,000 people would have no Affordable Care Act (ACA) carriers in 2018.
After the Healthcare Leadership Council (HLC) hosted a Capitol Hill bringing addressing the need for innovation in the nation’s healthcare workforce, the concerns now remain on how the industry is supposed to modernize during a time of varying factors.
U.S. lawmakers are considering a legislative proposal that would reauthorize the Prescription Drug User Fee Act (PDUFA) and potentially drive innovation in the pharmaceutical industry and among regulators.
Speculation that Republican Senate leaders will draft a health care bill that is hugely different than the measure that passed the House is "vastly overstated," Tom Miller, a resident fellow at the American Enterprise Institute, said.
Over one year ago, the U.S. Department of Health and Human Services (HHS) released their National Pain Strategy initiatives to help equip providers with the proper tools to institute better treatments for pain-centered ailments.